Histogen Inc.
SEC CIK 1383701 · HSTO · last insider filing 2023-06-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kisner Daniel L | Director | filed 2014 - 2023 |
| Fuhrmann Rochelle | Director | filed 2021 - 2023 |
| Windham-Bannister Susan Richards | Director | filed 2021 - 2023 |
| Crean David Hugh | Director | filed 2020 - 2023 |
| Jackson Jonathan | Director | filed 2020 - 2023 |
| Satz Brian | Director | filed 2020 - 2023 |
| Mento Steven J | Director · President, CEO & Director | filed 2013 - 2023 |
| Pascoe Richard W | Director · See Remarks | filed 2020 - 2021 |
| Chang Stephen | Director | filed 2020 - 2020 |
| Zhang Yizhuo | Director | filed 2020 - 2020 |
| Scott Kathleen D. | Director | filed 2019 - 2019 |
| Hale David F | Director | filed 2013 - 2019 |
| Larue William R | Director | filed 2017 - 2019 |
| Klassen Preston | Director | filed 2014 - 2019 |
| Van Wart Harold | Director | filed 2013 - 2019 |
| Scopa James Paul | Director | filed 2013 - 2018 |
| Malik Shahzad | Director | filed 2013 - 2016 |
| Lacasse Louis P | Director | filed 2013 - 2015 |
| Klingenstein Paul H | Director | filed 2013 - 2014 |
| Perret Marc Olivier | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Reyes Joyce | See Remarks | filed 2022 - 2023 |
| Knudson Susan A. | See Remarks | filed 2020 - 2023 |
| Spada Alfred P. | See Remarks | filed 2013 - 2023 |
| Latterich Martin | See Remarks | filed 2020 - 2022 |
| Naughton Gail K | See Remarks | filed 2020 - 2021 |
| Daniels Moya | See Remarks | filed 2020 - 2021 |
| Marshall Keith W | EVP, COO & CFO | filed 2017 - 2020 |
| Vandertie Michelle L | Vice President, Finance | filed 2017 - 2019 |
| Hagerty David T | EVP, Clinical Development | filed 2014 - 2019 |
| Smith Edward F III | SVP, Reg Affairs and QA | filed 2016 - 2019 |
| Ripley Daniel L. | SVP, Bus Dev, P&A Mgmt | filed 2017 - 2019 |
| Cashion Charles | SVP, Finance, CFO and Sec. | filed 2013 - 2017 |
| Burgess Gary C. | Sr. VP, Clin. Res. & CMO | filed 2013 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.